Please login to the form below

Not currently logged in
Email:
Password:

Andrew Witty appointed president of EFPIA

The European Federation of Pharmaceutical Industries and Associations has appointed Andrew Witty, CEO of GlaxoSmithKline, as its new president

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has appointed Andrew Witty, CEO of GlaxoSmithKline (GSK), as its new president. Witty will succeed outgoing president, Arthur Higgins, CEO of Bayer Healthcare.

 

Andrew Witty

 Andrew Witty
 


Commenting on his appointment, Witty said: "I am pleased to have the opportunity to represent our industry in Europe at this challenging time, when the policy considerations of healthcare have probably never been more pertinent. I thank Arthur Higgins for the focus he brought to the role of president, and the solid base it provides. As a result of his efforts, we are well prepared for future engagement and cooperation with the new Commission, European Parliament, Member States, patients and other stakeholders."

Witty, who has been vice-president of the EFPIA since 2008, went on to say: "Europe needs a 21st century approach to healthcare; one that provides access to optimal and equitable quality of care in a manner that is sustainable. We need policies that make this a reality, as well as policies that recognise innovation, equipping us to develop new medicines and therapies that citizens seek."

Higgins is also relinquishing his post at Bayer, for personal reasons. He is expected to be replaced by Marijn Dekkers, formerly of Thermo Fisher Scientific.

7th January 2010

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...
Oh no… not more training
Paul Hutchings, founder of fox&cat, discusses ways to help your team manage pressure in a more human, pressure-centric and engaging way...

Infographics